•
Dec 31, 2021

Stoke Therapeutics Q4 2021 Earnings Report

EPS
-$0.66
Previous year: -$0.42
+57.1%
Cash and Equivalents
$145M
Free Cash Flow
-$16.5M
Total Assets
$239M

Stoke Therapeutics

Stoke Therapeutics